# VERTEX PHARMACEUTICA (VRTX) — Q3-2018 Earnings Results

**Report date:** 2018-10-24 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/VRTX/earnings/Q3-2018

## Post-Earnings Brief

### Headline

Vertex Pharmaceuticals Beats on EPS, Stock Down 6.36%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.09 | N/A | +5.25% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record for the earnings call, so the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Vertex Pharmaceuticals reported an EPS of $1.09, beating expectations slightly. However, the stock fell by 6.36%, indicating investor concerns despite the earnings beat. The lack of revenue information and guidance may have contributed to the negative stock reaction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/VRTX/earnings/Q3-2018_